These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 239055)

  • 21. The in vivo role of murine natural killer cells in the development of B cell lineage in bone marrow.
    Tamauchi H; Shimamura K; Okumura K; Habu S; Tamaoki N
    Tokai J Exp Clin Med; 1985 Dec; 10(6):621-9. PubMed ID: 3915838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunochemical studies on Brucella abortus lipopolysaccharides.
    Marx A; Ionescu J; Pop A
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Feb; 253(4):544-53. PubMed ID: 6407237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Composition, structure, and biological properties of lipopolysaccharides from different strains of Pseudomonas syringae pv. atrofaciens].
    Zdorovenko GM; Zdorovenko EL; Varbanets LD
    Mikrobiologiia; 2007; 76(6):774-89. PubMed ID: 18297868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunocycte stimulation in vitro by nontoxic bacterial lipopolysaccharide derivatives.
    Frank S; Specter S; Nowotny A; Friedman H
    J Immunol; 1977 Sep; 119(3):855-60. PubMed ID: 330757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of detoxification processes on the interferon-inducing activity of bacterial endotoxins.
    Sourek J; Jandejsek J; Levin J
    Acta Microbiol Hung; 1989; 36(4):439-43. PubMed ID: 2484274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification and biological characterizationof endotoxin fractions from Pasteruella haemolytica.
    Rimsay RL; Coyle-Dennis JE; Lauerman LH; Squire PG
    Am J Vet Res; 1981 Dec; 42(12):2134-8. PubMed ID: 7041705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of latex-insolubilized endotoxins with murine macrophages: phagocytic responses of endotoxin-responsive (C3HeB/FeJ) and -unresponsive (C3H/HeJ) macrophages in vitro.
    Lubinsky-Mink S; Munkenbeck P; Morrison DC
    J Reticuloendothel Soc; 1983 May; 33(5):353-67. PubMed ID: 6842465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiation of lymphocytes in the mouse bone marrow. III. The adoptive response of bone marrow cells to a thymus cell-independent antigen.
    Stocker JW; Osmond DG; Nossal GJ
    Immunology; 1974 Nov; 27(5):795-806. PubMed ID: 4279889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunostimulation of C3H/HeJ lymphoid cells by R-chemotype lipopolysaccharide preparations.
    Flebbe L; Vukajlovich SW; Morrison DC
    J Immunol; 1989 Jan; 142(2):642-52. PubMed ID: 2642946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic action of lipopolysaccharide and tumor-promoting phorbol esters: two-signal requirement for colony-stimulating factor production by murine bone marrow cells.
    Pluznik DH; Mergenhagen SE
    Exp Hematol; 1986 Dec; 14(11):1029-36. PubMed ID: 2946598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The graft-versus-host reaction and immune function. IV. B cell functional defect associated with a depletion of splenic colony-forming units in marrow of graft-versus-host-reactive mice.
    Seddik M; Seemayer TA; Lapp WS
    Transplantation; 1986 Feb; 41(2):242-7. PubMed ID: 3511585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of cyclophosphamide on antibody formation in the mouse.
    Willers JM; Sluis E
    Ann Immunol (Paris); 1975 Apr; 126(3):267-79. PubMed ID: 1101799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural polymorphisms of rough mutant lipopolysaccharides Rd to Ra from Salmonella minnesota.
    Seydel U; Koch MH; Brandenburg K
    J Struct Biol; 1993; 110(3):232-43. PubMed ID: 8373704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro transformation of mouse bone-marrow-derived (B) lymphocytes induced by the lipid component of endotoxin.
    Rosenstreich DL; Nowotny A; Chused T; Mergenhagen SE
    Infect Immun; 1973 Sep; 8(3):406-11. PubMed ID: 4581010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endotoxic glycolipid from a heptoseless mutant of Salmonella minnesota.
    Kasai N; Nowotny A
    J Bacteriol; 1967 Dec; 94(6):1824-36. PubMed ID: 4965363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bone marrow colony-stimulating factor and tumor resistance-enhancing activity of postendotoxin mouse sera.
    Butler RC; Abdelnoor AM; Nowotny A
    Proc Natl Acad Sci U S A; 1978 Jun; 75(6):2893-6. PubMed ID: 351621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endotoxic glycolipid as a potent depressor of the hepatic drug-metabolizing enzyme systems in mice.
    Egawa K; Kasai N
    Microbiol Immunol; 1979; 23(2):87-94. PubMed ID: 459949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular requirements of endotoxin (ET) actions: changes in the immune adjuvant, TNF liberating and toxic properties of endotoxin during alkaline hydrolysis.
    Somlyo B; Csanky E; Shi XM; Zhang YL; Kovats E; Bona-Liptak E; Nowotny AM; Tripodi D; Nowotny A
    Int J Immunopharmacol; 1992 Feb; 14(2):131-42. PubMed ID: 1624214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological activities of fragments derived from Bordetella pertussis endotoxin: isolation of a nontoxic, Shwartzman-negative lipid A possessing high adjuvant properties.
    Ayme G; Caroff M; Chaby R; Haeffner-Cavaillon N; Le Dur A; Moreau M; Muset M; Mynard MC; Roumiantzeff M; Schulz D; Szabó L
    Infect Immun; 1980 Mar; 27(3):739-45. PubMed ID: 6247278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The adjuvant effect of bacterial endotoxin: its active component and action mechanism].
    Nakano M
    Nihon Rinsho; 1974 Aug; 32(8):2715-22. PubMed ID: 4612210
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.